CDX2 as a marker for intestinal differentiation: Its utility and limitations

Area of Science:

• Molecular Biology
• Developmental Biology
• Oncology

Background:

• CDX2 is a nuclear homeobox transcription factor crucial for embryonic development of the alimentary tract.
• It regulates intestinal cell proliferation, differentiation, adhesion, and apoptosis.
• CDX2 expression is organ-specific, found in the nuclei of epithelial cells throughout the gastrointestinal tract.

Purpose of the Study:

• To review the diagnostic utility of CDX2 in gastrointestinal tumors.
• To discuss its role in neoplasms with intestinal differentiation.
• To address limitations of CDX2 as a sole predictor for metastatic carcinomas.

Main Methods:

• Literature review of studies on CDX2 expression and diagnostic applications.
• Analysis of CDX2 specificity in various neoplasms.
• Evaluation of CDX2's role in differentiating primary and metastatic cancers.

Main Results:

• CDX2 is a specific marker for enterocytes and is valuable in diagnosing primary and metastatic colorectal adenocarcinoma.
• Its expression pattern is consistent in normal gastrointestinal epithelial cells from duodenum to rectum.
• CDX2 aids in identifying gastrointestinal origin in tumors with intestinal differentiation.

Conclusions:

• CDX2 is a significant diagnostic marker for gastrointestinal tumors, particularly colorectal adenocarcinoma.
• Its organ-specific expression aids in identifying neoplasms of intestinal origin.
• Limitations exist when using CDX2 as the sole indicator for metastatic carcinoma origin.